Rani Therapeutics Holdings, a clinical-stage biotherapeutics company based in San Jose, California, focuses on developing oral delivery technologies like the RaniPill capsule for biologics and drugs. The company went public on July 30, 2021, and has a pipeline that includes multiple drug candidates.